{"id":10650,"date":"2026-01-31T13:28:40","date_gmt":"2026-01-31T12:28:40","guid":{"rendered":"https:\/\/usamedical.com\/en\/?post_type=product&p=10650"},"modified":"2026-08-20T15:15:45","modified_gmt":"2026-08-20T22:15:45","slug":"usa-medical-cbd-oil-1000-mg-30-ml","status":"publish","type":"product","link":"https:\/\/usamedical.com\/en\/product\/usa-medical-cbd-oil-1000-mg-30-ml\/","title":{"rendered":"CBD Oil 1,000 mg"},"content":{"rendered":"
\n

Relax. Unwind. Ease Into Sleep.<\/h2>\n

A gentle everyday 1,000 mg broad-spectrum CBD oil built around relaxation, letting everyday stress go, and making the transition into sleep feel easier. The orange-flavored 30 mL dropper makes the ritual simple, measurable, and easy to repeat.<\/p>\n

\nWhat the research says<\/span><\/p>\n

Interesting signals. Formulation, dose, and goal still matter.<\/h3>\n

CBD research includes encouraging anxiety-related signals. A 2024 meta-analysis reported an overall benefit across eight small studies, while also showing substantial variation among trials.[2]<\/a> A separate randomized trial reported improvement with a specific nanodispersible oral CBD solution in adults with mild-to-moderate anxiety.[3]<\/a> Neither result is a clinical test of this broad-spectrum oil.<\/p>\n

Sleep findings are less consistent. A small 150 mg nightly CBD trial found selected objective signals but no clear overall improvement in insomnia severity, sleep-onset latency, or time awake after sleep onset.[4]<\/a> A later meta-analysis found that CBD-only therapies did not significantly improve subjective sleep quality overall.[5]<\/a><\/p>\n

Our honest read: CBD can be a thoughtful part of an evening routine, but this product is not a sleeping pill or a treatment for anxiety. The credible promise here is a clearly labeled, easy-to-use CBD ritual with evidence and limits kept visible.<\/p>\n<\/div>\n

\n
1,000 mg<\/strong>CBD per 30 mL bottle<\/span><\/div>\n
\n
30 mL dropper<\/strong>A familiar format for a repeatable routine.<\/span><\/div>\n
33.3 mg per serving<\/strong>Approximate CBD amount per standardized 1 mL serving.<\/span><\/div>\n
Broad-spectrum + orange<\/strong>Hemp-derived cannabinoids in an orange-flavored oil.<\/span><\/div>\n
Potency record visible<\/strong>The archived 2022 cannabinoid report is available to inspect.<\/span><\/div>\n<\/div>\n<\/div>\n

What CBD Is For<\/h3>\n
\n
\n

Relaxation + easier bedtime<\/h3>\n

A simple evening cue for unwinding from everyday stress and settling into the night.<\/p>\n<\/div>\n

\n

One clear serving<\/h3>\n

Every strength now uses the same 1 mL serving standard, giving each 30 mL bottle 30 measured servings.<\/p>\n<\/div>\n

\n

Research-led, never hype-led<\/h3>\n

We show where CBD evidence is promising, where it is mixed, and when a study used a different preparation or amount.<\/p>\n<\/div>\n

\n

Broad-spectrum format<\/h3>\n

The archived label identifies this as broad-spectrum hemp oil. That describes the extract format; it does not prove a specific outcome.<\/p>\n<\/div>\n

\n

Orange-finished oil<\/h3>\n

Grape seed oil, hemp seed oil, and organic orange oil complete the archived formula for a simple flavored dropper experience.<\/p>\n<\/div>\n

\n

Potency you can inspect<\/h3>\n

The available 2022 report recorded 1,077.9204 mg total CBD per package and total THC not detected in the tested sample. It is archived evidence, not current-batch proof.<\/p>\n<\/div>\n<\/div>\n

Choose the Strength That Fits Your Routine<\/h3>\n
\n
Bottle strength<\/span>Best fit<\/span>1 mL serving<\/span><\/div>\n
500 mg<\/strong>Precision low-strength option.<\/span>Approx. 16.7 mg CBD per serving.<\/span><\/div>\n
1,000 mg<\/strong>Gentle everyday starting point. This product.<\/span>Approx. 33.3 mg CBD per serving.<\/span><\/div>\n
3,000 mg<\/strong>Flagship high-strength option for experienced routines.<\/span>100 mg CBD per serving.<\/span><\/div>\n<\/div>\n
\n
\n

Go deeper with the Cannabinoid Encyclopedia<\/h3>\n

The Cannabinoid Encyclopedia is a separate educational project from the USA Medical team. It does not sell products. Its role here is to keep longer evidence reviews and primary sources separate from product claims.<\/p>\n

CBD and anxiety-related outcomes \u2197<\/span><\/a>
CBD and sleep-related outcomes \u2197<\/span><\/a><\/p>\n<\/div>\n

\n

Know the safety context<\/h3>\n

CBD can interact with medicines, cause drowsiness, and affect the liver. The FDA also emphasizes that many consumer CBD products have not been evaluated for safe dosing or effectiveness.[1]<\/a>[7]<\/a><\/p>\n

CBD side-effects research \u2197<\/span><\/a>
CBD and drug interactions \u2197<\/span><\/a><\/p>\n<\/div>\n<\/section>\n

\"CBD
Relax. Let everyday stress go. Ease into sleep.<\/figcaption><\/figure>\n
\n
\n

Works Cited<\/h2>\n<\/header>\n
\n
\n
Official consumer guidance<\/span>01<\/span><\/div>\n

FDA consumer CBD update<\/h3>\n

FDA summarizes the regulatory status of consumer CBD products and known or potential risks, including liver injury, medicine interactions, drowsiness, and unanswered dosing questions.<\/p>\n

Read the FDA update \u2197<\/span><\/a><\/div>\n<\/article>\n
\n
Meta-analysis \u00b7 2024<\/span>02<\/span><\/div>\n

CBD and anxiety outcomes<\/h3>\n

This meta-analysis pooled eight studies with 316 participants and reported an overall anxiety signal. Its wide interval, small evidence base, and varied designs limit product-specific conclusions.<\/p>\n

Read on PubMed \u2197<\/span><\/a><\/div>\n<\/article>\n
\n
Randomized trial \u00b7 2024<\/span>03<\/span><\/div>\n

Oral CBD solution and anxiety<\/h3>\n

This trial studied a specific nanodispersible oral CBD solution in adults with mild-to-moderate anxiety. It did not test this oil, label serving, or broad-spectrum formula.<\/p>\n

Read on PubMed \u2197<\/span><\/a><\/div>\n<\/article>\n
\n
Pilot trial \u00b7 2024<\/span>04<\/span><\/div>\n

CBD and insomnia<\/h3>\n

Thirty adults with insomnia used 150 mg CBD nightly for two weeks. Selected objective measures changed, but overall insomnia severity and several core sleep outcomes did not differ clearly from placebo.<\/p>\n

Read on PubMed \u2197<\/span><\/a><\/div>\n<\/article>\n
\n
Meta-analysis \u00b7 2025<\/span>05<\/span><\/div>\n

Cannabinoids and sleep quality<\/h3>\n

This review found no significant overall subjective sleep-quality benefit for CBD-only therapies, reinforcing why a CBD page should not promise sleep results.<\/p>\n

Read on PubMed \u2197<\/span><\/a><\/div>\n<\/article>\n
\n
Label analysis \u00b7 2017<\/span>06<\/span><\/div>\n

CBD labeling accuracy<\/h3>\n

A published analysis found frequent differences between labeled and measured cannabinoid content in online CBD products, showing why product-specific, lot-aware testing matters.<\/p>\n

Read on PubMed \u2197<\/span><\/a><\/div>\n<\/article>\n
\n
Systematic review \u00b7 2024<\/span>07<\/span><\/div>\n

CBD and medicine interactions<\/h3>\n

This systematic review describes clinically relevant interaction mechanisms and reinforces the need for professional review when CBD is used with medicine.<\/p>\n

Read on PubMed \u2197<\/span><\/a><\/div>\n<\/article>\n<\/div>\n